ArticleThe Journal of experimental medicine2018

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.

Zinal S Chheda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.